MTAP and cancer: This unique methodology for directly assessing metabolite-dependent drug-target engagement in live cells has the potential to significantly enhance our understanding of drug mechanisms and accelerate the development of precision medicines, particularly in contexts where metabolite levels play a critical role in drug sensitivity, such as in MTAP-deleted cancers.